VolitionRX Ltd (VNRX)

Stock chart
Ticker: VNRX Exchange: ASE


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Eight Corp Ltd
1 sale — total 18,000 USD
Sale 2 Jan 2024
Value US$2,747,324.00 | Price 297.54 | Shares 64,544
Sale 15 Dec 2023
Value US$4,904,976.85 | Price 493.01 | Shares 83,809
Sale 28 May 2021
Value US$35,400.00 | Price 3.54 | Shares 10,000
Buy 17 May 2021
Value US$173,500.00 | Price 3.47 | Shares 50,000
Buy 14 May 2021
Value US$6,400.00 | Price 3.20 | Shares 2,000
Buy 14 May 2021
Value US$329,000.00 | Price 3.29 | Shares 100,000
Sale 5 Feb 2021
Value US$53,700.00 | Price 5.37 | Shares 10,000
Sale 2 Dec 2020
Value US$34,000.00 | Price 3.40 | Shares 10,000
Sale 18 Nov 2020
Value US$690.00 | Price 3.45 | Shares 200
Sale 18 Nov 2020
Value US$10,817.15 | Price 3.35 | Shares 3,229
Sale 17 Nov 2020
Value US$5,341.40 | Price 3.40 | Shares 1,571
Sale 15 Sep 2020
Value US$62,985.00 | Price 3.23 | Shares 19,500
Sale 9 Sep 2020
Value US$208,650.00 | Price 3.21 | Shares 65,000
Buy 22 May 2020
Value US$11,000.00 | Price 2.75 | Shares 4,000
Buy 5 Dec 2019
Value US$4,664.00 | Price 4.24 | Shares 1,100
Buy 1 Oct 2019
Value US$284,570.00 | Price 5.69 | Shares 50,000
Sale 26 Sep 2019
Value US$278,792.02 | Price 6.03 | Shares 46,238
Buy 27 Aug 2019
Value US$37,500.00 | Price 3.75 | Shares 10,000
Buy 15 Aug 2019
Value US$197,000.00 | Price 3.94 | Shares 50,000
Buy 11 Jun 2019
Value US$31,400.00 | Price 3.14 | Shares 10,000
Buy 11 Jun 2019
Value US$214,733.90 | Price 3.10 | Shares 69,269
Buy 10 Jun 2019
Value US$213,607.62 | Price 3.02 | Shares 70,731
Buy 16 Aug 2018
Value US$99,652.00 | Price 2.00 | Shares 49,826
Buy 16 Aug 2018
Value US$27.86 | Price 1.99 | Shares 14
Buy 16 Aug 2018
Value US$13.79 | Price 1.97 | Shares 7
Buy 16 Aug 2018
Value US$298.35 | Price 1.95 | Shares 153
Buy 16 Aug 2018
Value US$9,550.00 | Price 1.91 | Shares 5,000
Buy 16 Aug 2018
Value US$12,415.00 | Price 1.91 | Shares 6,500
Buy 19 Sep 2017
Value US$7,810.00 | Price 2.84 | Shares 2,750
Buy 16 Aug 2017
Value US$10,055.10 | Price 2.77 | Shares 3,630
Buy 16 Aug 2017
Value US$10,055.10 | Price 2.77 | Shares 3,630
Buy 5 Oct 2016
Value US$50,000.00 | Price 5.00 | Shares 10,000
Sale 20 May 2016
Value US$12,000.60 | Price 3.54 | Shares 3,390
Buy 15 May 2015
Value US$340.99 | Price 3.41 | Shares 100
Buy 15 May 2015
Value US$4,647.86 | Price 3.32 | Shares 1,400
Buy 11 Feb 2015
Value US$187,500.00 | Price 3.75 | Shares 50,000
Buy 24 Sep 2014
Value US$159,773,864.80 | Price 18,748.40 | Shares 8,522
Buy 24 Sep 2014
Value US$22,274,000.00 | Price 7,000.00 | Shares 3,182
Buy 15 Sep 2014
Value US$10,800.00 | Price 2.16 | Shares 5,000
Sale 3 Sep 2014
Value US$10,800.00 | Price 1.80 | Shares 6,000
Sale 3 Sep 2014
Value US$18,000.00 | Price 1.80 | Shares 10,000
Sale 3 Sep 2014
Value US$21,600.00 | Price 1.80 | Shares 12,000
Buy 10 Mar 2014
Value US$15,026,403.84 | Price 4,206.72 | Shares 3,572
Buy 10 Mar 2014
Value US$1,780,625,899.52 | Price 45,793.28 | Shares 38,884
Buy 2 Dec 2013
Value US$48,779,512.20 | Price 9,999.90 | Shares 4,878
Buy 25 Nov 2013
Value US$35,852,247,664.20 | Price 271,102.70 | Shares 132,246
Buy 14 Nov 2013
Value US$1,896,201.90 | Price 1,898.10 | Shares 999
Buy 14 Nov 2013
Value US$38,785,660.92 | Price 7,951.14 | Shares 4,878
Buy 25 Mar 2013
Value US$6,564,701,840.24 | Price 114,583.22 | Shares 57,292
Buy 30 Sep 2005
Value US$1,000.00 | Price 0.05 | Shares 20,000
Buy 30 Sep 2005
Value US$5,000.00 | Price 0.05 | Shares 100,000
Buy 30 Sep 2005
Value US$2,500.00 | Price 0.05 | Shares 50,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-03 2024-01-02 S Sale Large shareholder
64,544 -16.8%
297.54
US$2,747,324
64,544 -16.8% 297.54 US$2,747,324
2023-12-20 2023-12-15 S Sale Large shareholder
83,809 +49.1%
493.01
US$4,904,977
83,809 +49.1% 493.01 US$4,904,977
2021-06-02 2021-05-28 S Sale

Chief Medical Officer

Officer
92,949 -47.1%
87.06
US$4,883,606
92,949 -47.1% 87.06 US$4,883,606
2021-05-18 2021-05-17 B Purchase Non-Executive Director
50,000 +3.4%
3.47
US$173,500
50,000 +3.4% 3.47 US$173,500
2021-05-18 2021-05-14 B Purchase Non-Executive Director
2,000 +400.0%
3.20
US$6,400
2,000 +400.0% 3.20 US$6,400
2021-05-18 2021-05-14 B Purchase Non-Executive Director
100,000 +7.2%
3.29
US$329,000
100,000 +7.2% 3.29 US$329,000
2021-02-08 2021-02-05 S Sale

Chief Medical Officer

Officer
10,000 -22.2%
5.37
US$53,700
10,000 -22.2% 5.37 US$53,700
2020-12-04 2020-12-02 S Sale

Chief Medical Officer

Officer
10,000 -18.2%
3.40
US$34,000
10,000 -18.2% 3.40 US$34,000
2020-11-19 2020-11-18 S Sale

Chief Medical Officer

Officer
200 -0.4%
3.45
US$690
200 -0.4% 3.45 US$690
2020-11-19 2020-11-18 S Sale

Chief Medical Officer

Officer
3,229 -5.5%
3.35
US$10,817
3,229 -5.5% 3.35 US$10,817
2020-11-19 2020-11-17 S Sale

Chief Medical Officer

Officer
1,571 -2.6%
3.40
US$5,341
1,571 -2.6% 3.40 US$5,341
2020-09-18 2020-09-15 S Sale

Chief Medical Officer

Officer
19,500 -35.8%
3.23
US$62,985
19,500 -35.8% 3.23 US$62,985
2020-09-10 2020-09-09 S Sale Non-Executive Director
65,000 -4.1%
3.21
US$208,650
65,000 -4.1% 3.21 US$208,650
2020-05-22 2020-05-22 B Purchase

President and CEO

Executive Director
4,000 +0.4%
2.75
US$11,000
4,000 +0.4% 2.75 US$11,000
2019-12-06 2019-12-05 B Purchase Reynolds Cameron John

President and CEO

Executive Director
1,100 +0.1%
4.24
US$4,664
1,100 +0.1% 4.24 US$4,664
2019-10-18 2019-10-01 B Purchase Large shareholder
50,000 +0.4%
5.69
US$284,570
50,000 +0.4% 5.69 US$284,570
2019-09-30 2019-09-26 S Sale Large shareholder
46,238 -0.4%
6.03
US$278,792
46,238 -0.4% 6.03 US$278,792
2019-08-28 2019-08-27 B Purchase Faulkes Martin Charles Non-Executive Director
10,000 +0.6%
3.75
US$37,500
10,000 +0.6% 3.75 US$37,500
2019-08-16 2019-08-15 B Purchase Faulkes Martin Charles Non-Executive Director
50,000 +3.3%
3.94
US$197,000
50,000 +3.3% 3.94 US$197,000
2019-06-13 2019-06-11 B Purchase
10,000 +0.7%
3.14
US$31,400
10,000 +0.7% 3.14 US$31,400
2019-06-13 2019-06-11 B Purchase
69,269 +4.9%
3.10
US$214,734
69,269 +4.9% 3.10 US$214,734
2019-06-12 2019-06-10 B Purchase
70,731 +5.2%
3.02
US$213,608
70,731 +5.2% 3.02 US$213,608
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
49,826 +3.8%
2.00
US$99,652
49,826 +3.8% 2.00 US$99,652
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
14 +0.0%
1.99
US$28
14 +0.0% 1.99 US$28
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
7 +0.0%
1.97
US$14
7 +0.0% 1.97 US$14
2018-08-20 2018-08-16 B Purchase Innes Guy Archibald Non-Executive Director
153 +0.0%
1.95
US$298
153 +0.0% 1.95 US$298
2018-08-17 2018-08-16 B Purchase Rootsaert Rodney Gerard

Secretary

Officer
5,000 +103.6%
1.91
US$9,550
5,000 +103.6% 1.91 US$9,550
2018-08-17 2018-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
6,500 +0.6%
1.91
US$12,415
6,500 +0.6% 1.91 US$12,415
2017-09-19 2017-09-19 B Purchase Vanston David Cecil

CHIEF FINANCIAL OFFICER

2,750 +inf%
2.84
US$7,810
2,750 +inf% 2.84 US$7,810
2017-08-17 2017-08-16 B Purchase Reynolds Cameron John

President and CEO

Executive Director
3,630 +0.4%
2.77
US$10,055
3,630 +0.4% 2.77 US$10,055
2017-08-17 2017-08-16 B Purchase Rootsaert Rodney Gerard

Secretary

3,630 +0.4%
2.77
US$10,055
3,630 +0.4% 2.77 US$10,055
2016-10-06 2016-10-05 B Purchase KRATOCHVIL DAVID MATTHEW

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000
10,000 +inf% 5.00 US$50,000
2016-05-24 2016-05-20 S Sale Reynolds Cameron John

President and CEO

Executive Director
3,390 -10.5%
3.54
US$12,001
3,390 -10.5% 3.54 US$12,001
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
100 +0.0%
3.41
US$341
100 +0.0% 3.41 US$341
2015-05-18 2015-05-15 B Purchase Reynolds Cameron John

President and CEO

Executive Director Large shareholder
1,400 +0.1%
3.32
US$4,648
1,400 +0.1% 3.32 US$4,648
2015-02-13 2015-02-11 B Purchase Innes Guy Archibald Non-Executive Director
50,000 +4.5%
3.75
US$187,500
50,000 +4.5% 3.75 US$187,500
2014-09-29 2014-09-24 B Purchase Innes Guy Archibald Non-Executive Director
8,522 +0.8%
18,748.40
US$159,773,865
8,522 +0.8% 18,748.40 US$159,773,865
2014-09-29 2014-09-24 B Purchase Colman Alan Non-Executive Director
3,182 +6.3%
7,000.00
US$22,274,000
3,182 +6.3% 7,000.00 US$22,274,000
2014-09-17 2014-09-15 B Purchase Faulkes Martin Charles Non-Executive Director
5,000 +0.5%
2.16
US$10,800
5,000 +0.5% 2.16 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
6,000 -0.6%
1.80
US$10,800
6,000 -0.6% 1.80 US$10,800
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
10,000 -0.5%
1.80
US$18,000
10,000 -0.5% 1.80 US$18,000
2014-09-03 2014-09-03 S Sale Rootsaert Rodney Gerard

Secretary

Officer
12,000 -0.6%
1.80
US$21,600
12,000 -0.6% 1.80 US$21,600
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
3,572 +0.3%
4,206.72
US$15,026,404
3,572 +0.3% 4,206.72 US$15,026,404
2014-03-12 2014-03-10 B Purchase Innes Guy Archibald Non-Executive Director
38,884 +3.6%
45,793.28
US$1,780,625,900
38,884 +3.6% 45,793.28 US$1,780,625,900
2013-12-04 2013-12-02 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
9,999.90
US$48,779,512
4,878 +0.5% 9,999.90 US$48,779,512
2013-12-04 2013-11-25 B Purchase Innes Guy Archibald Non-Executive Director
132,246 +14.2%
271,102.70
US$35,852,247,664
132,246 +14.2% 271,102.70 US$35,852,247,664
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
999 +0.1%
1,898.10
US$1,896,202
999 +0.1% 1,898.10 US$1,896,202
2013-11-18 2013-11-14 B Purchase Innes Guy Archibald Non-Executive Director
4,878 +0.5%
7,951.14
US$38,785,661
4,878 +0.5% 7,951.14 US$38,785,661
2013-11-18 2013-03-25 B Purchase Innes Guy Archibald Non-Executive Director
57,292 +6.6%
114,583.22
US$6,564,701,840
57,292 +6.6% 114,583.22 US$6,564,701,840
2005-11-28 2005-09-30 B Purchase THACHUK MARY ANNE

Secretary Treasurer

Officer
20,000 +inf%
0.05
US$1,000
20,000 +inf% 0.05 US$1,000
2005-11-28 2005-09-30 B Purchase THACHUK E DEL

CEO and President

Executive Director
100,000 +inf%
0.05
US$5,000
100,000 +inf% 0.05 US$5,000
2005-11-23 2005-09-30 B Purchase Brooke Brian Gordon

Chief Financial Officer

Executive Director
50,000 +inf%
0.05
US$2,500
50,000 +inf% 0.05 US$2,500
Explore more

More insider trading research around VolitionRX Ltd